Skip to main content
Fig. 8 | Journal of Experimental & Clinical Cancer Research

Fig. 8

From: Peglated-H1/pHGFK1 nanoparticles enhance anti-tumor effects of sorafenib by inhibition of drug-induced autophagy and stemness in renal cell carcinoma

Fig. 8

HGFK1 suppresses sorafenib-induced cancer stemness in RCC. a Ketr-3 and ACHN cells were treated with sorafenib and/or rHGFK1 for 48 h, then analyzed the expression of CD133, Nanog, and Oct4 with Western-Blotting. b Mammosphere formation assay was used to analyze the cancer stemness of Ketr-3 and ACHN cells after treated with sorafenib and/or rHGFK1

Back to article page

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us